Top biotech and pharmaceutical companies market cap 2024

Top biotech and pharmaceutical companies market cap 2024 - Statista

As of early March 2024, Eli Lilly had a market cap of nearly 740 billion U.S..

Top 20 biopharmas' market cap rises 2% in Q3 2024 amid flurry of ...

The top 20 biopharmaceutical companies demonstrated signs of recovery during the third quarter (Q3) of 2024 as investor optimism improved ...

Largest Biotech companies by Market Cap

favorite icon, 17. Regeneron Pharmaceuticals logo. Regeneron Pharmaceuticals. 17REGN ; Close Ad X ; favorite icon, 18. Zoetis logo. Zoetis. 18ZTS ; favorite icon ...

Top biotech and pharmaceutical companies market cap 2024 | Statista

As of early March 2024, Eli Lilly had a market cap of nearly 740 billion U.S. dollars and thus was the leader among big pharma companies ...

Top 10 Largest Publicly Traded Pharma and Biotech Companies in ...

Top 10 Largest Publicly Traded Pharma and Biotech Companies in 2024 by Market Cap · 1. Johnson & Johnson (JNJ) · 2. Novo Nordisk (NVO) · 3. Eli ...

Largest pharma companies by market cap

Largest pharma companies by market cap ; favorite icon, 2. Novo Nordisk logo. Novo Nordisk. 2NVO ; favorite icon, 3. Johnson & Johnson logo. Johnson & Johnson. 3 ...

The Top 25 Biotechnology Companies of 2024

1. Clario. For over 50 years, Clario has established itself as a leading healthcare research and technology company, headquartered in ...

Top 25 Biotech Companies of 2024

Just missing the list at number 26 is BioMarin Pharmaceutical, which had a market cap of $17.51 billion on December 8, followed by WuXi ...

Top 20 biopharmas' market cap up 4.3% in Q2 2024 as GLP-1 drug ...

Eli Lilly achieved the largest market capitalisation growth of 16.3% over Q2 2024, surpassing $800bn (Figure 1). Lilly's growth is attributed to ...

Who are the top 10 pharmaceutical companies in the world? (2024)

THE PHARMACEUTICAL MARKET IN 2023 · 1. Pfizer - US$58.5bn · 2. Johnson & Johnson - US$54.76bn · 3. AbbVie - US$54.32bn · 4. Merck & Co - US$53.6bn.

Exploring the top 20 biopharma companies Q1 2024 market cap ...

Of the top 20 biopharmaceutical companies to see a profitable Q1 in 2024, Lilly leads with a 33.7% increase, with Nordisk in second, ...

Pharma Stocks: 5 Biggest Companies in 2024 | Nasdaq

Pharma Stocks: 5 Biggest Companies in 2024 · With the pharmaceutical sector projected to reach a · With that in mind, the Investing News Network ...

30 Most Valuable Drug Companies in 2024 - Yahoo Finance

According to a report by The Business Research Company, the global pharmaceutical drugs market was estimated to have reached a value of $1.19 ...

Top 20 global biopharmaceutical companies report 9.6% market ...

Ophelia Chan, MSc, Business Fundamentals Analyst at GlobalData, comments: “Lilly maintains its lead with the largest market capitalization ...

Top 20 Biopharma Companies of 2024 - PharmaShots

With a CAGR of 7.8 %, the global biopharma industry is anticipated to register a market size of $799.76B by 2030. In 2023, JNJ ranked first in ...

Who are the Top-10 Biggest Companies in Global Pharma in 2024?

In 2023, Eli Lilly, the American pharmaceutical company, emerged as the world's largest pharma firm, boasting a market capitalization of $717.3 ...

Biotech Stocks: The Top 5 To Watch As Shares Broadly Struggle

1 Biotech Stock: Catalyst Pharma ... Catalyst has rejoined the list of top biotech stocks. The company licenses already or soon-to-be approved ...

Who Will the Next “Big Pharma” Players Be? - BioSpace

... top 20 biopharma companies by market cap in Q1 2024. ... Like other biotech companies ... Many of the largest pharmaceutical companies ...

Fourteen biotech companies with market caps exceeding $100 billion

Table of contents · Bristol Myers Squibb – $102 billion · Regeneron Pharmaceuticals – $108 billion · Sanofi – $110 billion · Vertex Pharmaceuticals ...

List of largest biomedical companies by market capitalization

The following is a list of independent pharmaceutical, biotechnology and medical companies listed on a stock exchange (as indicated) with current market ...